CJC-1295 No DAC Research Overview
CJC-1295 no DAC is a growth hormone releasing hormone (GHRH) analogue peptide extensively utilised in metabolic and endocrinological laboratory research. This synthetic peptide represents an optimised form of naturally occurring GHRH(1-29) with specific amino acid substitutions at positions 2, 8, 15, and 27 that enhance stability and receptor binding characteristics. Unlike its DAC (Drug Affinity Complex) counterpart, this variant maintains the original short half-life profile, making it particularly valuable for researchers studying pulsatile growth hormone release patterns. The compound demonstrates high selectivity for GHRH receptors and has become a cornerstone reference material in growth hormone axis investigations. Leading research institutions worldwide have integrated CJC-1295 no DAC into their protocols for examining hypothalamic-pituitary interactions, with studies published in peer-reviewed endocrinology journals. Stroid UK Shop maintains stringent quality control standards to ensure consistent research outcomes.
Laboratory Research Applications
Investigators utilise CJC-1295 no DAC to examine growth hormone secretion dynamics in controlled experimental conditions. The peptide’s mechanism involves binding to GHRH receptors on anterior pituitary somatotrophs, stimulating adenylyl cyclase activation and subsequent growth hormone release. Research teams have employed this compound to analyse circadian rhythm influences on GH secretion, protein synthesis pathways, and metabolic regulatory mechanisms. Studies examining insulin-like growth factor-1 (IGF-1) expression patterns frequently incorporate CJC-1295 no DAC as a research tool. The peptide’s short duration of action allows researchers to investigate acute hormonal responses without prolonged system activation. Academic institutions studying age-related growth hormone decline have published data using this compound to assess pituitary responsiveness. CJC-1295 peptides remain essential tools for examining hypothalamic-pituitary-hepatic axis interactions. Comparative studies with other selective androgen receptor modulators and research peptides provide comprehensive insights into growth factor regulation.
Technical Specifications
| Parameter | Specification |
|---|---|
| Molecular Weight | 3367.97 g/mol |
| CAS Number | 863288-34-0 |
| Purity | ≥98% (HPLC) |
| Storage Temperature | -20°C (lyophilised) |
| Solubility | Water soluble |
| Peptide Length | 29 amino acids |
| Reconstitution | Bacteriostatic water |
| Stability | 2-8°C (reconstituted, 30 days) |
Research Compliance Statement
CJC-1295 no DAC is manufactured exclusively for in-vitro laboratory research applications and is not intended for human consumption, therapeutic use, or clinical application. This peptide is supplied to qualified research institutions, licensed laboratories, and academic facilities conducting studies under appropriate ethical oversight. Researchers must ensure compliance with institutional review board guidelines and relevant regulatory frameworks. The compound should be handled by trained personnel in appropriate laboratory environments with proper safety protocols. Storage recommendations must be followed to maintain peptide integrity and research reproducibility. All research activities must adhere to established scientific methodologies and legal requirements for peptide research in their respective jurisdictions.
